Back to Search
GREGORY FEY, M.D.
M.D.
Psychiatry Physician
NPI: 1811034705Individual
Specialties, Licenses & Credentials
Forensic Psychiatry Physician
Psychiatry & Neurology — Forensic Psychiatry
Code: 2084F0202X
D0058807(MD)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
D0058807(MD)
Research & Publications (20)
Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
PMID 19188138·Protein Eng Des Sel·2009
7-preclinical
A simple one-pot route to mesoporous silicas SBA-15 functionalized with exceptionally high loadings of pendant carboxylic acid groups.
PMID 19668835·Chem Commun (Camb)·2009
8-other
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability.
PMID 19262596·Leukemia·2009
4-observational
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
PMID 17665197·Cancer Immunol Immunother·2008
7-preclinical
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.
PMID 18691745·Cell·2008
7-preclinical
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
PMID 18337643·Melanoma Res·2008
8-other
Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists.
PMID 18199557·Cancer Res·2008
4-observational
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells.
PMID 17495978·Leukemia·2007
7-preclinical
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
PMID 16611304·Br J Haematol·2006
7-preclinical
Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
PMID 15604978·Clin Nucl Med·2005
5-case
Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
PMID 15833872·Cancer Res·2005
7-preclinical
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
PMID 16029450·Br J Haematol·2005
8-other
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
PMID 15194496·Biochem Biophys Res Commun·2004
7-preclinical
A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.
PMID 15059139·Br J Haematol·2004
7-preclinical
Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.
PMID 14980440·J Immunol Methods·2004
4-observational
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.
PMID 14764538·Blood·2004
8-other
A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.
PMID 12019163·Cancer Res·2002
7-preclinical
Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions.
PMID 11527155·J Cell Biochem·2001
8-other
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL.
PMID 11420702·Oncogene·2001
8-other
An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells.
PMID 11292491·J Immunol Methods·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 104A ANNAPOLIS ST
ANNAPOLIS, MD 21401 - Phone
- (410) 793-7050
Quick Facts
- NPI
- 1811034705
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile